-
Medical journals
- Career
Antibiotics and probiotics in acute pancreatitis
Authors: J. Lata; O. Stibůrek
Authors‘ workplace: Interní hepatogastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MU Dr. Jan Lata, CSc.
Published in: Vnitř Lék 2010; 56(6): 582-584
Category: 65th Birthday - Petr Svacina, MD
Overview
Severe acute pancreatitis is serious disease. High mortality is also due to infection complications. If we will be able to prevent the infection, it could diminish mortality. The role of prevention of infection with antibiotics and probiotics is discussed in the paper.
Key words:
acute pancreatitis – antibiotics – probiotics
Sources
1. Neoptolemos JP, Raraty M, Finch M et al. Acute pancreatitis: the substantial human and financial costs. Gut 1998; 42 : 886 – 891.
2. Isenmann R, Rünzi M, Kron M et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo ‑ controlled, double‑blind trial. Gastroenterology 2004; 126 : 997 – 1004.
3. Mazaki T, Ishii Y, Takayama T. Meta‑analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg 2006; 93 : 674 – 678.
4. Špičák J, Hejtmánková S, Hubaczová M et al. Antibiotická profylaxe infekčních komplikací u akutní pankreatitidy – výsledky randomizované studie s meropenemem. Čes Slov Gastroent Hepatol 2003; 57 : 222 – 227.
5. Powell JJ, Campbell E, Johnson CD et al. Survey of antibiotic prophylaxis in acute pancreatitis in the UK and Ireland. Br J Surg 1999; 86 : 320 – 322.
6. Banks BA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101 : 2379 – 2400.
7. Working Party of the British Society of Gastroenterology. UK guidelines for the management of acute pancreatitis. Gut 2005; 54 (Suppl 3): iii1 – iii9.
8. Cahn DR. Über die nach Gram färbbaren Bacillen des Säulingsstuhles (Bacilli of infant stools stainable according to Gram.) Centralblatt für Bakteriologie I. Abteilung Originale 1901; 30 : 721 – 726.
9. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66 : 365 – 378.
10. Lilly DM, Stillwell RH. Probiotics: growth ‑ promoting factors produced by microorganisms. Science 1965; 147 : 747 – 748.
11. Havenaar R, Ten Brink B, Huis in’t Veld JH. Selection of strains for probiotic use. In: Fuller R (ed). Probiotics: the scientific basis. London: Chapman and Hall 1992 : 209 – 224.
12. Döderlein A. Das Scheidensekret und seine Bedeutung für das Puerperalfieber (The vaginal transsudate and its significance for childbed fever). Centralblatt für Bacteriologie 1892; 11 : 699 – 700.
13. Metchnikoff E. Prolongation of life – Optimistic Studies. New York: Putnam & Sons 1908.
14. van Minnen LP. Acute pancreatitis – Surgery, pathophysiology, probiotic prophylaxis. Enschede: Gildeprint Drukkerijen BV 2006.
15. Oláh A, Belágyi T, Issekutz A et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89 : 1103 – 1107.
16. Timmerman HM, Koning CJ, Mulder L et al. Monostrain, multistrain and multispecies probiotics. A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96 : 219 – 233.
17. Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double‑blind, placebo ‑ controlled trial. Lancet 2008; 371 : 651 – 659.
18. Lata J, Juránková J, Stibůrek O et al. Probiotika u akutní pankreatitidy – randomizovaná, placebem kontrolovaná, dvojitě slepá studie. Vnitř Lék 2010; 56 : 111 – 114.
19. Jafri NS, Mahid SS, Idstein SR et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta‑analysis. Am J Surg 2009; 197 : 806 – 813.
20. Pezzilli R. Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta‑analytic studies? JOP 2009; 10 : 223 – 224.
Labels
Diabetology Endocrinology Internal medicine
Article was published inInternal Medicine
2010 Issue 6-
All articles in this issue
- Pulmonary hypertension – unusual complication of the bacterial overgrowth syndrome – editorial
- Is there circadian variation of big endothelin and NT‑proBNP in patients with severe congestive heart failure?
- The normalized smoothness index and parametric population RDH index of telmisartane in patients with newly diagnosed hypertension and metabolic syndrome
- Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of Register for the 1st quarter of 2010
- Pulmonary hypertension – unusual complication of haemolysis and the bacterial overgrowth syndrome
-
Hyperlipoproteinemie a dyslipoproteinemie I.
Klasifikace, diagnostika, kardiovaskulární, kardiometabolické a reziduální riziko - BRNO Register 2: post-myocardial infarction pharmacotherapy
- Different courses of recurrent or multisystem Langerhans cells histiocytosis in adults – description of 22 cases from one centre
- Sepsis and the septic shock in oncological or other immunocompromised patients
- A psychological perspective on the problems faced by the oncology patients and their care teams
- Antibiotics and probiotics in acute pancreatitis
- The value of various imaging techniques in diagnosing and monitoring the disease activity of multiple myeloma
- Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma
- Continuous monitoring of tissue glucose
- The value of baroreflex sensitivity for cardiovascular risk stratification in hypertensives
- Prevention and treatment of extremitovascular ischemic disease
- Changes in lipoprotein spectrum in patients with the diagnosis of extremito-vascular ischemic disease
- Universities need to have high quality education as well as an effective quality control of their students’ (products’) knowledge and skill base
- Internal Medicine
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Sepsis and the septic shock in oncological or other immunocompromised patients
-
Hyperlipoproteinemie a dyslipoproteinemie I.
Klasifikace, diagnostika, kardiovaskulární, kardiometabolické a reziduální riziko - Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of Register for the 1st quarter of 2010
- Different courses of recurrent or multisystem Langerhans cells histiocytosis in adults – description of 22 cases from one centre
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career